type
interferon
import
antivir
respons
coordin
innat
immun
respons
explor
use
adjuv
respons
rabi
viru
rv
vaccin
vector
express
gag
viral
load
immun
respons
immun
mice
analyz
time
result
indic
rv
express
ifn
highli
attenu
compar
control
rv
demonstr
express
reduc
viral
replic
approxim
despit
decreas
replic
mice
immun
ifn
rv
significantli
greater
number
activ
cell
increas
activ
cell
depend
signal
saw
differ
follow
infect
ifnar
mice
although
mice
immun
ifn
greater
primari
immun
respons
control
immun
mice
challeng
vaccinia
express
gag
signific
differ
number
function
cell
increas
cell
activ
presenc
even
greatli
reduc
viral
replic
indic
benefici
effect
host
tradit
vaccin
approach
liveattenu
virus
success
provid
immun
mankind
largest
microbi
threat
one
success
stori
use
attenu
vaccinia
viru
immun
peopl
smallpox
infect
parrino
graham
howev
similar
approach
use
fail
control
infecti
diseas
thu
vaccin
develop
requir
novel
approach
potenti
use
molecular
adjuv
increas
immun
respons
letvin
live
attenu
vaccin
vector
greatest
potenti
gener
broadscop
immun
use
shown
differ
set
gener
vaccin
vector
base
attenu
rabi
viru
rv
express
siv
antigen
proven
highli
immunogen
mice
protect
nonhuman
primat
aidslik
diseas
mcgettigan
et
al
mckenna
et
al
rv
envelop
nonseg
neg
strand
rna
viru
rhabdovirida
famili
although
wild
type
rv
almost
alway
caus
fatal
cn
diseas
mammalian
speci
dietzschold
faber
schnell
attenu
form
rv
prove
excel
vaccin
vector
faber
et
al
mcgettigan
et
al
mckenna
et
al
siler
et
al
furthermor
attenu
rv
shown
induc
strong
cellular
humor
immun
respons
foreign
gene
mcgettigan
et
al
mckenna
et
al
mckenna
et
al
rv
rel
simpl
genom
organ
encod
five
structur
protein
nucleoprotein
n
phosphoprotein
p
matrix
protein
glycoprotein
g
rnadepend
rna
polymeras
l
rvn
encapsid
viral
rna
togeth
rvp
polymeras
l
compos
ribonucleoprotein
rnp
complex
rvm
bridg
rnp
complex
transmembran
domain
rvg
mebats
weiland
conzelmann
rvm
rvg
facilit
virion
bud
infect
cell
mebats
konig
conzelmann
mebats
weiland
conzelmann
rv
lifecycl
thought
sensit
sever
antivir
protein
induc
type
interferon
ifn
thu
rv
develop
least
two
mechan
antagon
type
ifn
induct
signal
addit
serv
noncatalyt
cofactor
polymeras
l
rvp
also
inhibit
phosphoryl
interf
brzozka
fink
conzelmann
furthermor
ctermin
domain
rvp
bind
coilcoil
domain
effici
prevent
nuclear
accumul
brzozka
fink
conzelmann
vidi
chelbialix
blondel
vidi
et
al
thu
rvp
interfer
induct
signal
type
interferon
type
interferon
although
origin
recogn
antivir
properti
recent
gain
recognit
role
coordin
innat
adapt
immun
respons
type
ifn
express
may
bia
immun
respons
toward
respons
wenner
et
al
addit
play
import
role
clonal
expans
antigenspecif
cell
adopt
transfer
interferon
receptor
knockout
cell
wild
type
host
highlight
necess
signal
cell
induc
surviv
lcmvspecif
cell
prolif
phase
kolumam
et
al
type
ifn
affect
cell
respons
also
shown
augment
immun
respons
activ
antigen
present
cell
apc
dendrit
cell
dc
matur
follow
infect
lcmv
montoya
et
al
herp
simplex
viru
pollara
et
al
shown
type
ifn
depend
addit
subsequ
transfect
two
recombin
adenoviru
ad
vector
seen
dc
upregul
express
phenotyp
activ
marker
increas
independ
viral
replic
toll
like
receptor
tlr
signal
howev
margin
increas
costimulatori
molecul
surfac
bmdc
deriv
mice
suggest
matur
adtransduc
cell
depend
type
ifn
signal
hensley
et
al
furthermor
follow
matur
presenc
type
interferon
gmcsf
monocytederiv
dc
effect
stimul
antigenspecif
cell
respons
dc
matur
gmcsf
santodonato
et
al
appar
play
import
role
direct
adapt
immun
respons
function
also
suggest
may
valuabl
adjuv
vaccin
develop
howev
much
work
support
immunemodifi
function
done
vitro
therefor
potenti
use
ifn
adjuv
vaccin
develop
need
investig
attempt
induc
express
vaccin
respiratori
syncyti
viru
rsv
martinezsobrido
et
al
insert
rsvf
protein
newcastl
diseas
viru
ndv
vaccin
vector
although
recombin
viru
increas
level
predict
protect
mice
rsv
challeng
mechan
protect
unclear
similar
protect
seen
wild
type
mice
martinezsobrido
et
al
combin
multipl
viral
protein
may
imposs
distinguish
direct
effect
interferon
immunolog
respons
addit
protein
furthermor
differ
virus
sever
distinct
featur
addit
abil
induc
ifn
make
result
difficult
analyz
use
system
express
rv
vaccin
vector
order
compar
immun
respons
induc
presenc
absenc
increas
level
use
promot
induct
stronger
cell
respons
might
benefici
certain
vaccin
approach
although
littl
evid
avail
link
benefici
outcom
rv
infect
increas
ctl
respons
rv
vaccin
vector
increas
ctl
respons
foreign
antigen
may
requir
order
investig
potenti
immuneenhanc
effect
construct
two
recombin
rabi
virus
one
express
gag
express
gag
minu
atg
start
codon
data
support
hypothesi
work
interfac
innat
adapt
immun
respons
sustain
pool
activ
antigenspecif
lymphocyt
thu
addit
control
viral
replic
wellstudi
effect
type
ifn
provid
evid
also
direct
cell
adapt
immun
system
adequ
respond
pathogen
elucid
immunemodifi
effect
type
ifn
import
determin
whether
addit
cytokin
enhanc
cellular
respons
increas
potenc
rv
base
vaccin
vector
investig
effect
type
interferon
adapt
immun
respons
use
previous
wellcharacter
rv
vaccin
vector
encod
gag
figur
denot
bnspgag
mcgettigan
et
al
purpos
gene
encod
mous
introduc
rv
g
l
gene
result
viru
express
gag
figur
denot
ifn
note
well
establish
express
addit
gene
chang
growth
characterist
rv
mcgettigan
et
al
thu
order
proper
control
also
clone
mous
gene
without
atg
start
codon
rv
g
l
gene
figur
denot
ifn
recombin
virus
recov
standard
method
previous
describ
tan
et
al
evalu
express
two
recombin
rv
ifn
ifn
product
quantifi
viral
supernat
via
elisa
h
post
infect
figur
detect
background
level
supernat
bsr
cell
infect
ifn
presum
due
ifn
antagonist
activ
rvp
brzozka
fink
conzelmann
brzozka
fink
conzelmann
vidi
chelbialix
blondel
vidi
et
al
hand
bsr
cell
infect
ifn
viru
produc
approxim
increas
background
next
aim
assess
biolog
function
express
recombin
rv
briefli
infect
bsr
cell
ifn
ifn
bnsp
hour
supernat
sampl
collect
uvinactiv
serial
dilut
supernat
use
pretreat
mous
na
cell
h
prior
infect
na
cell
recombin
vsv
express
gfp
stojdl
et
al
five
hour
infect
vsvgfp
na
cell
analyz
express
gfp
marker
vsv
replic
system
type
ifn
known
effici
inhibit
vsv
replic
neuron
trottier
palian
reiss
thu
function
present
supernat
see
gfp
express
shown
figur
supernat
ifn
infect
cell
effici
inhibit
vsv
replic
indic
presenc
function
sampl
express
determin
immunostain
infect
bsr
cell
recombin
rv
bnsp
ifn
ifn
analyz
antibodi
direct
rvn
result
indic
virus
infect
cell
figur
antirvn
ifn
ifn
rv
express
gag
figur
determin
whether
express
gag
rv
genom
alter
growth
kinet
rv
analyz
viral
growth
multistep
onestep
growth
curv
well
document
potent
antivir
therefor
analyz
growth
kinet
type
ifn
respons
nonrespons
cell
determin
na
bsr
cell
produc
type
ifn
follow
sendai
viru
infect
two
howev
na
cell
respons
mous
thu
abl
inhibit
vsv
replic
data
shown
cell
infect
moi
multistep
onestep
aliquot
supernat
collect
variou
time
point
titer
determin
multistep
onestep
growth
curv
deriv
infect
bsr
cell
illustr
ifn
ifn
virus
grew
similar
kinet
rel
equal
titer
figur
c
indic
express
affect
viral
growth
type
ifn
independ
mechan
note
titer
ifn
ifn
virus
less
titer
parent
viru
strain
bnspgag
time
point
presum
due
insert
gene
rv
g
rv
l
howev
sensit
cell
use
signific
differ
growth
kinet
ifn
ifn
rv
onestep
multistep
growth
curv
delay
viral
growth
approxim
log
decreas
final
titer
ifn
viru
figur
thu
express
rv
exhibit
antivir
properti
grown
ifn
sensit
cell
order
character
increas
express
follow
rv
infect
would
impact
immunogen
pathogen
rv
vaccin
vector
balbc
mice
immun
intranas
ffu
ifn
ifn
infect
mice
intranas
order
see
effect
pathogen
shown
first
gener
vaccin
vector
bnspgag
apathogen
peripher
inocul
still
lethal
intranas
intracrani
inocul
mcgettigan
et
al
saw
surviv
mice
infect
ifn
viru
significantli
greater
surviv
mice
infect
recombin
rv
express
figur
expect
suggest
express
result
increas
surviv
ifn
immun
mice
next
sought
determin
whether
increas
surviv
due
antivir
activ
immunemodifi
activ
mice
immun
intranas
ifn
ifn
brain
spleen
infect
anim
taken
variou
time
post
infect
viral
rna
brain
quantifi
use
qpcr
specif
rvn
previous
describ
tan
et
al
shown
figur
averag
decreas
viral
messeng
rna
day
decreas
mrna
day
mice
infect
ifn
viru
compar
mice
infect
control
ifn
viru
note
viral
genom
rna
day
lower
messeng
rna
mous
data
shown
thu
vivo
express
similar
attenu
effect
viral
growth
seen
tissu
cultur
effici
decreas
viral
load
first
day
infect
splenocyt
mice
analyz
evalu
immunemodifi
effect
rv
vaccin
vector
due
low
precursor
frequenc
antigenspecif
cell
wild
type
mous
look
percentag
activ
cell
hi
lo
lymphocyt
popul
show
immun
respons
entir
vaccin
vector
gag
protein
surprisingli
saw
despit
larg
decreas
viral
load
ifn
infect
anim
dpi
similar
number
activ
cell
recov
ifn
ifn
infect
anim
furthermor
dpi
signific
increas
percentag
activ
splenocyt
ifn
infect
anim
despit
decreas
viral
antigen
figur
thu
although
mice
infect
ifn
viru
probabl
lower
amount
viral
antigen
dpi
due
antivir
effect
mice
similar
day
significantli
greater
day
cell
respons
order
determin
whether
effect
specif
rout
immun
also
look
cell
activ
inguin
lymph
node
spleen
mice
immun
intramuscularli
consist
seen
intranas
immun
dpi
signific
differ
activ
cell
found
ifn
ifn
immun
mice
data
shown
thu
conclud
primari
immun
respons
act
adjuv
cellular
immun
type
ifn
also
shown
affect
antibodi
develop
follow
influenza
infect
heer
et
al
determin
impact
express
humor
immun
respons
vaccin
strategi
mice
bled
variou
time
post
infect
sera
analyz
rvg
antibodi
seen
total
igg
level
increas
mice
began
lose
weight
figur
ifn
immun
mice
appreci
rvg
igg
level
sera
earlier
timepoint
ifn
immun
mice
moreov
three
seven
ifn
mice
never
develop
rvinduc
patholog
also
never
produc
antirv
antibodi
indic
innat
immun
respons
via
clear
rv
infect
conclud
experi
humor
respons
determin
larg
part
viral
replic
determin
whether
delay
kinet
antibodi
product
mice
vaccin
ifn
due
persist
infect
ifn
rv
quantifi
viral
messeng
rna
day
mice
first
exhibit
sign
diseas
dpi
mice
lowest
bodi
weight
saw
day
level
viral
rna
messag
decreas
mice
around
copi
viral
rna
figur
note
one
mous
high
level
viral
messeng
rna
dpi
lowest
amount
viru
thu
possibl
kinet
viral
replic
mous
highli
delay
therefor
seem
unlik
ifn
viru
persist
long
term
mice
rather
kinet
viral
replic
may
delay
addit
order
establish
differ
seen
balbc
mice
depend
express
repeat
evalu
viral
load
immunogen
interferon
receptor
knockout
ifnar
mice
type
ifn
signal
heterodimer
receptor
initi
jakstat
signal
pathway
randal
goodbourn
one
receptor
subunit
knock
mice
render
unabl
initi
signal
cascad
muller
et
al
follow
immun
mice
receiv
either
ifn
ifn
immun
show
signific
differ
surviv
figur
likewis
dpi
signific
differ
amount
viral
messeng
rna
isol
brain
mice
immun
ifn
ifn
vaccin
vector
figur
addit
percentag
hi
lo
cell
popul
equal
mice
immun
ifn
ifn
figur
taken
togeth
data
suggest
differ
observ
wild
type
balbc
mice
immun
ifn
ifn
virus
due
signal
order
fulli
understand
role
primari
immun
respons
follow
viral
infect
sought
determin
express
act
increas
level
cell
activ
sever
group
seen
act
antigen
present
cell
macrophag
dendrit
cell
induc
upregul
costimulatori
molecul
turn
may
gener
greater
cell
respons
altern
may
act
directli
cell
contribut
activ
test
first
hypothesi
infect
macrophag
cell
line
dendrit
jawsii
cell
line
ifn
ifn
virus
variou
hour
post
infect
analyz
activ
apc
determin
express
follow
infect
macrophag
cell
either
ifn
ifn
dramat
upregul
hpi
figur
howev
signific
differ
fold
increas
uninfect
cell
express
compar
ifn
ifn
infect
cell
time
point
similarli
saw
follow
infect
jawsii
cell
either
ifn
ifn
rv
equal
induc
upregul
express
figur
order
clearli
distinguish
effect
rv
infect
supplementari
experi
perform
supernat
ifn
ifn
infect
jawsii
cell
use
activ
uninfect
jawsii
cell
signific
differ
activ
state
determin
express
jawsii
cell
treat
uvinactiv
supernat
ifn
ifn
infect
cell
compar
cell
treat
uninfect
supernat
thu
seem
incorpor
rv
construct
significantli
increas
dc
activ
therefor
seem
unlik
differ
observ
cell
activ
result
increas
costimul
apc
appear
increas
matur
apc
therefor
next
investig
impact
antigenspecif
cell
popul
vaccin
strategi
determin
direct
effect
cell
develop
transfer
model
cell
mous
either
wild
type
respons
ifn
nonrespons
ifn
briefli
isol
cell
balbc
mice
transfer
cell
intraperiton
nude
mice
figur
nude
mice
small
number
matur
cell
limit
function
peripheri
kindr
kishihara
et
al
yoshikai
rei
mak
transfer
model
cell
abl
respond
infect
transfer
mice
one
day
prior
infect
ifn
viru
analyz
splenocyt
saw
differ
percentag
activ
cell
spleen
balbc
ifnar
recipi
mice
dpi
figur
howev
notic
total
number
cell
recov
balbc
recipi
mice
tend
greater
number
recov
mice
figur
trend
approach
signific
compar
cell
number
p
howev
signific
compar
cell
number
conclud
signal
may
import
sustain
popul
antigenspecif
cell
follow
infect
proof
principl
vaccin
studi
challeng
model
assess
effect
develop
longterm
memori
cell
key
requir
vaccin
intramuscularli
im
immun
mice
ffu
ifn
ifn
previous
shown
peripher
inject
bnsp
base
vaccin
vector
pathogen
immun
compet
mice
mcgettigan
et
al
likewis
clinic
sign
rabi
detect
follow
im
immun
ifn
ifn
vector
data
shown
immun
balbc
mice
rest
least
day
challeng
intraperiton
ip
plaqu
form
unit
pfu
vaccinia
viru
express
gag
vvgag
gag
specif
recal
respons
analyz
day
later
evalu
express
gag
specif
cell
receptor
tcr
specif
tetram
addit
function
memori
cell
determin
intracellular
cytokin
stain
signific
differ
number
tetram
posit
cell
present
follow
immun
ifn
ifn
rv
figur
howev
ifn
immun
mice
seem
fall
group
high
respond
low
respond
percentag
tetram
cell
less
consid
function
cell
saw
differ
induct
cytokin
ifn
ifn
immun
anim
figur
express
induc
highest
level
littl
induc
taken
togeth
result
indic
although
enhanc
primari
immun
respons
figur
adjuv
effect
viral
vaccin
vector
induc
minim
longterm
benefit
reflect
longterm
memori
respons
analyz
effect
viral
replic
primari
cell
activ
memori
cell
develop
order
assess
use
molecular
adjuv
vaccin
develop
see
express
effici
decreas
viral
titer
reduc
vector
pathogen
figur
therefor
could
ad
rvbase
vaccin
vector
reduc
vectorassoci
pathogen
increas
safeti
furthermor
antivir
activ
could
potenti
lead
selflimit
infect
make
appeal
use
immunocompromis
individu
increas
express
type
ifn
prime
signific
effect
cellular
immun
respons
despit
significantli
less
viral
antigen
significantli
greater
percentag
activ
cell
spleen
dpi
figur
highlight
potenti
strength
use
adjuv
vaccin
develop
although
signific
effect
primari
immun
respons
memori
immun
respons
seem
unaffect
addit
rv
vaccin
vector
figur
hypothes
antivir
activ
prime
counterbalanc
immuneenhanc
capabl
thu
signific
increas
memori
cell
format
achiev
rv
vaccin
vector
alreadi
shown
safe
mcgettigan
et
al
mckenna
et
al
show
addit
genom
work
attenu
viru
recombin
ifn
ifn
virus
attenu
compar
parent
bnspgag
seen
reduct
titer
time
point
growth
curv
figur
viral
replic
significantli
decreas
depend
manner
reaffirm
antivir
effect
type
ifn
negativesens
rna
virus
randal
goodbourn
addit
second
gene
rv
genom
antivir
activ
attenu
rv
vaccin
vector
attenu
seen
vivo
increas
surviv
ifn
immun
mice
figur
addit
attenu
viru
saw
abl
significantli
increas
cellular
immun
respons
follow
immun
surprisingli
saw
dpi
cell
activ
significantli
greater
follow
infect
ifn
viru
despit
note
decreas
viral
load
furthermor
less
viru
brain
dpi
still
equal
activ
cell
respons
fact
indic
potent
adjuv
cellular
immun
furthermor
studi
mice
indic
differ
seen
type
ifn
depend
data
support
use
enhanc
immun
respons
vaccin
vector
given
even
low
moi
order
understand
adjuv
properti
sought
determin
mechan
increas
primari
cell
respons
follow
immun
ifn
viru
hand
apc
activ
seem
affect
increas
level
infect
rv
howev
viral
infect
induc
apc
matur
type
ifn
independ
manner
similarli
dc
matur
follow
sendai
viru
infect
shown
work
independ
ifn
pathway
lopez
et
al
although
strong
correl
dc
matur
type
ifn
induct
observ
determin
use
antiifn
antibodi
secret
ifn
neither
necessari
suffici
induc
full
dc
matur
lopez
et
al
furthermor
seen
follow
adenoviru
infect
type
ifn
necessari
dc
undergo
full
matur
howev
wildtyp
mice
could
mount
strong
antigenspecif
cell
respons
hensley
et
al
therefor
surpris
differ
saw
cell
activ
presenc
absenc
exogen
function
dc
macrophag
activ
instead
immuneenhanc
activ
vaccin
strategi
seem
directli
impact
cell
although
transfer
experi
definit
prove
need
sustain
popul
antigenspecif
cell
experi
support
conclus
therefor
like
signal
receptor
cell
requir
either
signal
promot
differenti
effector
cell
signal
resist
activationinduc
cell
death
seen
treatment
requir
cell
prime
induc
prolifer
cytolyt
activ
bead
coat
mhc
ipeptid
costimulatori
ligand
unabl
suffici
prime
cell
howev
cell
stimul
bead
presenc
capabl
cytolyt
function
product
curtsing
et
al
hand
also
prevent
activationinduc
cell
death
cell
follow
nonspecif
activ
staphylococc
enterotoxin
b
marrack
kappler
mitchel
model
allow
us
distinguish
two
possibl
howev
support
direct
role
prime
piec
evid
import
consid
vaccin
develop
despit
undeni
adjuv
effect
induc
saw
primari
immun
respons
see
signific
increas
antigenspecif
cell
follow
vvgag
challeng
month
later
howev
much
less
antigen
site
viral
replic
brain
mice
suggest
exist
divers
repertoir
cell
singl
epitop
antigen
load
influenc
vitro
recal
respons
naumov
et
al
furthermor
antigen
dose
influenc
qualiti
cell
induc
follow
infect
studi
done
alexandermil
seen
higher
avid
cell
induc
lower
peptid
concentr
howev
also
observ
lower
avid
cell
preferenti
surviv
memori
cell
alexandermil
therefor
sinc
memori
cell
differenti
also
impact
amount
antigen
immuneenhanc
effect
may
counterbalanc
low
antigen
load
thu
yield
minim
chang
overal
memori
cell
develop
thu
may
better
adjuv
choic
dna
subunit
vaccin
vaccin
vector
deleteri
impact
cytokin
anoth
consider
made
type
ifn
report
differ
effect
cell
variou
activ
state
result
signal
activ
cell
differ
respons
cell
human
cell
pretreat
ifna
delay
entri
cell
cycl
hand
presenc
ifna
follow
nonspecif
stimul
human
cell
antibodi
inhibit
cell
prolifer
dondi
et
al
studi
howev
consid
type
ifn
effect
cell
memori
precursor
cell
thu
despit
posit
impact
effector
cell
prime
littl
conclud
whether
effect
memori
precursor
cell
gene
encod
mous
porfmifnb
invitrogen
use
templat
amplifi
pcr
use
vent
polymeras
new
england
biolab
inc
primer
contain
bsiwi
nhei
restrict
site
underlin
result
pcr
fragment
gel
purifi
digest
bsiwi
nhei
digest
product
ligat
plasmid
encod
recombin
rv
vaccin
vector
pspbn
mcgettigan
et
al
previous
digest
bsiwi
nhei
result
plasmid
design
pspbnifn
altern
mous
amplifi
pcr
use
primer
contain
bsiwi
nhei
restrict
site
underlin
lack
atg
start
codon
pcr
fragment
gel
purifi
bsiwi
nhei
digest
ligat
bsiwinheidigest
pspbn
result
plasmid
design
pspbnifn
plasmid
encod
recombin
rv
vaccin
vector
express
gag
pbnspgag
describ
previous
mcgettigan
et
al
pspbnifn
pspbnifn
plasmid
digest
pml
nco
digest
fragment
contain
either
ifn
ifn
gene
ligat
pbnspgag
previous
digest
pml
nco
gener
plasmid
design
ifn
ifn
respect
introduc
sequenc
plasmid
confirm
sequenc
recombin
rv
virion
recov
system
describ
previous
tan
et
al
briefli
fugen
transfect
reagent
roch
diagnost
use
cotransfect
plasmid
bsr
cell
cell
clone
plate
concentr
plasmid
per
plate
follow
recombin
rv
cdna
rv
n
ug
polymeras
rv
p
rv
l
rv
g
plasmid
encod
recombin
rv
cdna
rv
n
p
g
l
control
promot
fink
muellerwaldeck
conzelmann
plasmid
encod
polymeras
control
chicken
actin
promot
enhanc
cmv
immedi
earli
gene
day
transfect
supernat
collect
well
bsr
cell
stain
fluorescein
isothiocyn
fitc
conjug
antirv
n
antibodi
centacor
inc
identifi
well
infecti
viru
supernat
rvposit
well
use
infect
flask
bsr
cell
increas
viral
yield
immunostain
bsr
cell
infect
multipl
infect
moi
either
bnsp
ifn
ifn
hour
h
media
aspir
cell
fix
aceton
minut
min
cell
wash
pb
stain
human
monoclon
antibodi
nih
aid
research
refer
reagent
program
min
rt
cell
wash
pb
stain
secondari
antibodi
donkey
antihuman
igg
jackson
immunoresearch
final
concentr
altern
infect
cell
fix
aceton
stain
fitcconjug
anti
rvn
centacor
inc
h
stain
cell
wash
pb
fluoresc
observ
uv
microscop
bsr
cell
infect
moi
either
bnsp
ifn
ifn
h
left
uninfect
supernat
collect
spun
rpm
min
remov
cellular
debri
uvinactiv
min
uvinactiv
viral
supernat
bnsp
ifn
ifn
infect
cell
dilut
ad
neuroblastoma
na
cell
follow
h
pretreat
na
cell
infect
vsvgfp
moi
h
vsv
replic
determin
fluoresc
uv
light
sourc
bsr
na
cell
infect
bnspgag
ifn
ifn
serumfre
media
moi
onestep
growth
curv
multistep
growth
curv
follow
min
incub
viru
aspir
cell
wash
twice
pb
remov
viru
yet
infect
cell
serumcontain
media
ad
cell
indic
time
point
supernat
remov
store
aliquot
titer
duplic
bsr
cell
week
old
balbc
mice
mice
balbc
background
martinezsobrido
et
al
maintain
thoma
jefferson
univers
anim
facil
mice
infect
either
intramuscularli
intranas
sucros
purifi
ifn
ifn
viru
weight
mice
monitor
daili
anim
euthan
lose
bodi
weight
andor
show
sever
clinic
sign
rabi
altern
immun
mice
euthan
day
post
infect
dpi
analyz
viral
load
paramet
immun
respons
serum
brain
spleen
harvest
time
point
analysi
mice
recal
respons
experi
rest
least
day
intramuscular
immun
ifn
ifn
challeng
intraperiton
ip
pfu
recombin
vacciniaexpress
gag
mice
euthan
day
challeng
spleen
harvest
analysi
transfer
experi
cell
isol
spleen
balbc
ifnar
mice
dynal
cell
neg
isol
kit
invitrogen
accord
manufactur
protocol
puriti
cell
assess
flow
cytometri
determin
cell
transfer
nude
mice
ip
one
day
transfer
mice
infect
ffu
ifn
intramuscularli
mice
euthan
day
immun
spleen
harvest
analysi
elisa
bsr
cell
infect
ifn
ifn
moi
left
uninfect
h
supernat
collect
spun
rpm
remov
cellular
debri
viral
supernat
dilut
amount
sampl
quantifi
use
mous
elisa
kit
pbl
biomed
laboratori
accord
manufactur
protocol
rvg
elisa
done
describ
previous
mcgettigan
et
al
briefli
maxisorb
plate
nunc
coat
purifi
rvg
protein
dilut
na
co
plate
wash
tween
pb
block
milkpb
min
rt
serum
collect
rvinfect
mice
variou
time
point
post
infect
dilut
pb
ad
plate
duplic
follow
h
incub
rt
plate
wash
tween
pb
goat
antimous
igg
conjugatedhrp
southern
biotech
ad
final
concentr
ngml
plate
incub
plate
wash
tween
pb
develop
ophenylenediamin
dihydrochlorid
fast
tablet
peroxidas
substrat
sigma
min
colorimetr
reaction
stop
h
absorb
well
determin
viru
load
brain
infect
mice
determin
taqman
probebas
realtim
pcr
describ
previous
tan
et
al
follow
modif
genom
rna
sampl
standard
equat
r
rv
messeng
rna
sampl
standard
equat
r
copi
number
normal
total
rna
surfac
stain
splenocyt
spleen
infect
mice
homogen
singlecel
suspens
prepar
erythrocyt
remov
ack
lyse
buffer
sigma
inc
splenocyt
count
trypan
blue
exclus
cell
wash
fac
buffer
bsapb
block
ice
h
rat
antimous
fc
block
bd
bioscienc
pharmigen
unconjug
streptavidin
fac
cell
wash
fac
buffer
stain
fluoresc
antibodi
min
rt
stain
cell
wash
fac
buffer
fix
cytofix
bd
bioscienc
hour
intern
stain
splenocyt
sampl
stimul
amqmlketi
peptid
left
unstimul
h
golgiblock
bd
bioscienc
ad
h
cell
stain
surfac
molecul
follow
fixat
cell
wash
twice
permwash
buffer
bd
bioscienc
stain
min
room
temperatur
intern
molecul
mice
immun
intranas
ffu
sucros
purifi
rv
survivorship
mice
monitor
kaplanmei
test
signific
saw
signific
increas
surviv
mice
immun
intranas
ifn
compar
immun
ifn
b
viral
messeng
rna
recov
brain
infect
mice
quantifi
use
real
time
pcr
day
infect
significantli
viru
detect
brain
mice
infect
ifn
viru
compar
mice
infect
ifn
viru
c
despit
lower
amount
viru
mice
infect
ifn
viru
significantli
greater
percentag
activ
hi
lo
cell
dpi
one
repres
mous
group
shown
c
also
averag
mice
per
group
time
point
horizont
line
indic
averag
valu
indic
p
valu
mice
immun
intranas
ffu
sucros
purifi
ifn
rv
c
e
ifn
rv
b
weight
fluctuat
monitor
time
b
blood
collect
mice
variou
time
post
immun
c
elisa
done
determin
total
igg
specif
rvg
given
day
rvg
specif
igg
format
delay
follow
immun
ifn
e
viral
messeng
rna
recov
brain
ifn
infect
mice
quantifi
use
real
time
pcr
day
infect
determin
infect
persist
horizont
line
indic
averag
valu
mice
immun
intranas
ffu
sucros
purifi
rv
survivorship
mice
monitor
kaplanmei
test
signific
saw
signific
differ
surviv
mice
immun
ifn
ifn
b
viral
messeng
rna
recov
brain
infect
mice
quantifi
use
real
time
pcr
day
infect
signific
differ
viral
load
found
mice
immun
ifn
ifn
c
differ
activ
hi
lo
cell
dpi
one
repres
mous
group
shown
c
also
averag
mice
per
group
time
point
horizont
line
indic
averag
valu
